Zenro Ikezawa
Yokohama City University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zenro Ikezawa.
British Journal of Dermatology | 2001
M. Aihara; Y. Sugita; S. Takahashi; T. Nagatani; S. Arata; K. Takeuchi; Zenro Ikezawa
Recently, it has been proposed that viral infection is involved in the pathogenesis of hypersensitivity syndrome. Cytomegalovirus (CMV), one of the aetiological agents of infectious mononucleosis, has never been reported as an organism associated with hypersensitivity syndrome. We describe a 64‐year‐old man with severe phenytoin‐induced hypersensitivity syndrome associated with CMV infection. Twenty‐five days after the patient was started on phenytoin, he developed high fever and a generalized erythematous rash followed by jaundice, renal failure and disseminated intravascular coagulopathy (DIC). CMV‐specific IgG antibodies were significantly increased 7 weeks after the onset of clinical symptoms and the increase was associated with the appearance of CMV‐specific IgM. CMV DNA was detected in the serum of the patient. Coinfection with other viruses, such as Epstein–Barr virus and human herpesviruses 6 and 7, could be excluded because antibody titres to those viruses did not increase during the clinical course of his illness. We suggest that reactivation of CMV may contribute, at least in some cases, to the development of hypersensitivity syndrome.
American Journal of Ophthalmology | 2015
Chie Sotozono; Mayumi Ueta; Eiji Nakatani; Amane Kitami; Hideaki Watanabe; Hirohiko Sueki; Masafumi Iijima; Michiko Aihara; Zenro Ikezawa; Yukoh Aihara; Yoko Kano; Tetsuo Shiohara; Mikiko Tohyama; Yuji Shirakata; Hideaki Kaneda; Masanori Fukushima; Shigeru Kinoshita; Koji Hashimoto
PURPOSE To suggest an objective score for grading the acute ocular severity of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), and to determine predictive factors for severe acute ocular involvement such as ocular surface epithelial defect and/or pseudomembrane formation. DESIGN Retrospective cohort study. METHODS The medical records of SJS (n = 87) and TEN (n = 48) patients between 2005 and 2007 were reviewed. An acute ocular severity score was determined on a scale from 0 to 3 (none, mild, severe, and very severe) according to the existence of hyperemia, corneal or conjunctival epithelial defect, and pseudomembrane formation. The associations between the severe acute ocular involvement and factors such as patient age, exposed drugs, systemic severity, and the prevalence of ocular sequelae were examined. RESULTS The number of cases with score grade 0, 1, 2, and 3 was 19 (21.8%), 31 (35.6%), 22 (25.3%), and 15 (17.2%) in 87 SJS cases and 12 (25.0%), 11 (22.9%), 17 (35.4%), and 8 (16.7%) in 48 TEN cases. Multivariate logistic regression analysis revealed that patient age (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.96-0.99; P = .007) and nonsteroidal anti-inflammatory drugs NSAIDs or cold remedies (OR, 2.58; 95% CI, 1.26-5.29; P = .010) were predictive factors for severe acute ocular involvement. The prevalence of visual disturbance and eye dryness increased according to the increase of acute ocular severity (P = .001 and P = .007 in SJS; P = .007 and P = .014 in TEN, respectively). CONCLUSIONS At the onset of SJS/TEN, strict attention should be paid to ocular involvement in young patients and in patients exposed to NSAIDs or cold remedies.
British Journal of Dermatology | 2011
Yusuke Inoue; Michiko Aihara; M. Kirino; I. Harada; J. Komori-Yamaguchi; Yukie Yamaguchi; Yoji Nagashima; Zenro Ikezawa
Background An increase in interleukin (IL)‐18 production from epidermal cells has been reported in an atopic dermatitis (AD) mouse model, and subsequent topical application of Staphylococcus aureus results in severe dermatitis.
Clinical and Translational Allergy | 2014
Yoshiro Saito; Mayumi Ueta; Ryosuke Nakamura; Emiko Sugiyama; Keiko Maekawa; Yukitoshi Takahashi; Hirokazu Furuya; Akiko Yagami; Setsuko Matsukura; Zenro Ikezawa; Kayoko Matsunaga; Chie Sotozono; Michiko Aihara; Shigeru Kinoshita; Nahoko Kaniwa
Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous adverse drug reactions that often induces the mucosal tissue impairments. These symptoms in ocular surface sometimes suffer the patients with pseudomembrane formation leading to vision loss as a sequela. The purpose of this study to reveal the medication tendencies for inducing severe ocular surface complications in SJS/TEN of Japanese populations.
The Journal of Allergy and Clinical Immunology | 2001
Yukoh Aihara; Takeshi Kotoyori; Yuriko Takahashi; Hiroyuki Osuna; Sumi Ohnuma; Zenro Ikezawa
Journal of environmental dermatology : the official journal of the Japanese Society for Contact Dermatitis | 2002
Setsuko Matsukura; Michiko Aihara; Zenro Ikezawa
Archive | 2010
Satoshi Miyata; Kaoru Miyazaki; Chie Yasuda; Akihiro Iwamatsu; Zenro Ikezawa; Michiko Aihara; Kayano Moriyama
Skin Cancer | 2007
Tetsuo Nagatani; Aiko Takano; Tsuyoshi Kanbara; Hidefumi Wada; Zenro Ikezawa
Journal of environmental dermatology : the official journal of the Japanese Society for Contact Dermatitis | 2002
Yuko Ikezawa; Michiko Aihara; Megumi Kondo; Sanami Takahashi; Kazuo Takahashi; Zenro Ikezawa
Journal of environmental dermatology and cutaneous allergology | 2012
Mayumi Nagashima; Takeshi Kambara; Michiko Aihara; Zenro Ikezawa